NeurologyLive Friday 5 — May 29, 2020

May 29, 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 29, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: CMSC 2020 Day 1: Peter Calabresi, MD, on CNS Immune Responses in Progressive MS

Peter Calabresi, MD, delivers the Whitaker Lecture as part of the 2020 CMSC Virtual Annual Meeting.

WATCH NOW

2: CMSC 2020 Day 2: Brenda Banwell, MD, on Current Perspectives of Pediatric MS Care and Research

Brenda Banwell, MD, presents her lecture titled, "Current Perspectives of Pediatric MS Care and Research" as part of the 2020 CMSC Virtual Annual Meeting.

WATCH NOW

3: Shadi Yaghi, MD: Incidence of Stroke in Patients With COVID-19

The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone gives perspective on his recent study of patients with stroke and COVID-19 and the difficulties in understanding their relationship.

WATCH NOW

4: Ocrelizumab Has Similar Effects in MS With Shorter Infusion Time

The Genentech agent, which is approved for patients with relapsing-remitting multiple sclerosis, showed no new safety signals in a comparison between conventional and shorter infusion times.

READ MORE

5: Reviewing a Case of Parkinson Disease OFF Episodes

Peter A. LeWitt, MD, offers expert perspective on the identification and management of OFF episodes in a 68-year-old man with Parkinson disease.

WATCH NOW